Support for the FH Europe Network in COVID19 crisis
Coronavirus, or COVID-19, has been declared a pandemic by the World Health Organisation. But what does this mean for those living with cholesterol or lipid conditions?
In response to this unprecedented health crisis, FH Europe decided to host biweekly virtual meetings to connect, to share and to support the Network. As a result of the ongoing exchange, we have collected some ideas and suggestions applied across Europe, which we have compiled in one document. You can access the “Good practices for FH Patient Organizations during the COVID19 crisis” pdf here.
Additionally, FH Europe co-authored together with international panel of experts a publication “Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic”, which has been submitted and accepted to Pharmacological Research. Soon to be available online.
We would like to inform you that FH Europe are happy to assist you with any related webinars you might wish to host in your local language, with your local experts. For more information please contact Magdalena Daccord directly on firstname.lastname@example.org.
FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt